Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Eur Urol. 2009 Mar 13;57(3):446–452. doi: 10.1016/j.eururo.2009.03.023

Table 3.

Coefficients for the relationship between prostate-specific antigen (PSA) and age for the Krimpen study, the Scandinavian Prostatic Cancer Group 4 (SPCG-4) cohort, and the UK cohort

Krimpen study SPCG-4 cohort UK cohort
PSA level at age 50, ng/ml (95% CI) 0.8
(0.7–0.8)
0.8 (0.6–1.2)   3.1
(2.7–3.6)
Relative increase in PSA per year in
age, % (95% CI)
  4.0
(3.7–4.5)
  16.4
(14.0–18.8)
  4.1
(3.1–5.2)

CI = confidence interval.